Chief Product & Tech. Officer Chandhok Nikhil sold $1.7M at $63.90, reducing his direct stake by 3.5% while trading just 3.4% above the 90-day low. This continues a pattern of consistent officer selling near lows, with five other BEARISH signals from CRCL insiders in the past month including Chandhok's own $35.4M sale on June 24. Bear: breaks $61.77 support → targets $50. Bull: reclaims $87.38 resistance → invalidates pattern.

Where it could go — Our 7-8 conviction officer sells: 34% beat SPY at 30d, avg -8.5% vs SPY.

Chairman and CEO Jeremy Allaire sold $4.0M worth of CRCL shares at $67.16, cutting his direct stake by 48.3% at a price just 8.7% above the 90-day low. This sale continues a pattern of aggressive insider selling, with four other officers liquidating significant stakes near lows in recent weeks, suggesting deep internal concern. Bear: breaks $61.77 support → targets $50–55.

Where it could go — Our 7-8 conviction officer sells: 33% beat SPY at 30d, avg -9.0% vs SPY; bear breaks $61.77.

Chairman and CEO Jeremy Allaire sold $204K worth of CRCL at $67.16, reducing his direct stake by 4.6% while the stock trades just 8.7% above its 90-day low. This continues a pattern of officer selling near lows, though the relatively small size compared to his recent $4.9M sale suggests limited immediate downside pressure.

Where it could go — Our 5-6 conviction officer sells: 52% beat SPY at 30d with +4.1% average outperformance; watch $61.77 as critical support.

Director Neville sold $3.1M of CRCL shares at $62.65, reducing his directly held stake by 96% while the stock traded just 1.4% above its 90-day low. This sale continues a consistent pattern of liquidation by insiders near price lows, suggesting ongoing internal concerns despite the stock's depressed valuation.

Where it could go — Our 5-6 conviction sells historically beat SPY 55% of the time at 30d; watch $61.77 as critical support, break below could signal further downside.

CCO Razzaghi sold $118K at $64.40, reducing his direct stake by 0.3% while the stock trades just 4.3% above its 90-day low. This continues a pattern of officer selling near lows, with four other bearish insider signals in the past month suggesting internal concern despite mixed analyst sentiment.

Where it could go — Our 5-6 conviction officer sells: 52% beat SPY at 30d with avg +4.7% vs SPY; watch $61.77 as critical support break level.

Chief Product Officer Chandhok Nikhil sold $35.4M worth of CRCL shares at $72.37, reducing his directly held stake by 40% while trading just 3.3% above the 90-day low. This massive sale—his largest ever—comes amid a cluster of recent officer sales and near multi-month lows, signaling deep insider concern about near-term prospects. Bear: breaks $70 support → targets $55-60; bull holds $70 and reclaims $85 resistance.

Where it could go — 9 similar CRCL signals avg -30.2% at 30d; bear breaks $70, bull holds $70.

President Tarbert Heath sold $3.2M worth of CRCL shares at $81.47, reducing his directly held stake by 7.2% at a price just 1.3% above the 90-day low. This sale is particularly significant as it occurred alongside four other CRCL officers selling on the same day near multi-month lows, indicating broad internal concern rather than isolated profit-taking. Breaks $77.87 support → targets $65-70; holds above $85 for potential relief rally.

Where it could go — Broad base rate 57.1% positive at 90d; bear breaks $77.87, bull holds $85.

Chief Commercial Officer Razzaghi Hossein sold $2.7M worth of CRCL at $78.85, just 1.3% above the 90-day low, reducing his directly held stake by 4.9%. This sale matters because it aligns with a cluster of other senior executives selling near lows, suggesting internal concern about near-term prospects despite the stock's 44% decline from highs. Bear: breaks $77.87 support → could test $70; bull: holds $78 and reclaims $85 for relief.

Where it could go — Broad base rate 57.1% positive at 90d; bear breaks $77.87, bull holds $78.

Director Neville sold $4.1M in CRCL shares at $81.30, reducing his stake by 96% while the stock traded just 8.4% above its 90-day low. This continues a pattern of aggressive selling by the director, with no offsetting buying from any other insiders, suggesting persistent internal concern.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $77.87 recent low.

Date Rajeev V exercised 2,546 options at $0.08 and sold the resulting shares at $84.38 ($215K). The sale came from newly exercised options and did not reduce previously held shares, leaving 154,346 directly held shares.

Where it could go — Exercise-and-sell transactions are largely mechanical and carry limited directional signal.

Chairman and CEO Jeremy Allaire sold $251K worth of CRCL shares at $82.93, reducing his stake by 4.5% while the stock traded just 5.8% above its 90-day low. This continues a pattern of insider selling with no offsetting buys, though the relatively small size compared to his $46M prior sales makes this less alarming.

Where it could go — Broad universe shows only 37.5% of similar setups lead to higher prices at 90d; watch $78.41 as critical support level.

Director Neville sold $85.7M in CRCL shares at $82.87, liquidating 99.8% of his remaining stake just 6.8% above the 90-day low. This massive liquidation near price lows, combined with no other insider buyers, suggests deep concern about near-term prospects despite the stock's depressed level.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $78.41 recent low.

Nikhil Chandhok, Chief Product & Tech. Officer, sold 26,666 shares at ~$83.75 ($2.2M); 23,333 shares came from a same-day option exercise at $25.81. The remaining 3,333 shares came from existing holdings, leaving 521,809 directly held shares.

Where it could go — Modest trim of existing holdings alongside a substantial option exercise — the 3,333-share reduction reflects a partial position trim, not a major unwind.

CFO Jeremy Fox-Geen sold $715K in CRCL, reducing his stake by 2.3% as the stock traded just 5.8% above its 90-day low. This sale is part of a long-running pattern of disposals by the CFO, but its timing near the low, combined with a lack of any insider buying, reinforces a cautious internal view.

Where it could go — Analyst mean target not provided; bear case if stock breaks the recent low of $78.41.

Chairman & CEO Jeremy Allaire sold $4.9M worth of CRCL at $82.93, reducing his stake by 48% at a price just 5.8% above the 90-day low. A CEO selling such a large portion of his holdings near a low, despite a mixed analyst consensus, suggests a lack of confidence in a near-term recovery. Bear: breaks the recent low of $78.41.

Where it could go — Broad base rate 37.5% positive at 90d; bear breaks $78.41.

Chief Accounting Officer Tamara Schulz sold $122,000 worth of CRCL shares in her first-ever transaction, reducing her stake by 1.3% while the stock trades significantly below recent highs. This isolated sale by a first-time seller lacks supporting cluster activity and occurs amid mixed analyst sentiment, suggesting limited predictive value.

Where it could go — Analyst mean target unavailable; bear case if stock breaks below $84 support level.

Director Neville Patrick Sean sold $1.5M worth of CRCL shares, reducing his stake by 44% at $106.22, which sits 24% below the 90-day high. This first-time director sale without supporting buyer activity suggests potential concern, though mixed analyst consensus (18 buy/14 hold) provides some counterbalance.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $97.69 support level.

Director Neville Patrick Sean sold $1.5M worth of CRCL shares, reducing his stake by 44% at $106.22, which sits 24% below the 90-day high. This first-time director sale without supporting buyer activity suggests potential concern, though mixed analyst consensus (18 buy/14 hold) provides some counterbalance.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $97.69 support level.

Director Neville Patrick Sean sold $1.5M worth of CRCL shares, reducing his stake by 44% at $106.22, which sits 24% below the 90-day high. This first-time director sale without supporting buyer activity suggests potential concern, though mixed analyst consensus (18 buy/14 hold) provides some counterbalance.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $97.69 support level.

Director Neville Patrick Sean sold $1.5M worth of CRCL shares, reducing his stake by 44% at $106.22, which sits 24% below the 90-day high. This first-time director sale without supporting buyer activity suggests potential concern, though mixed analyst consensus (18 buy/14 hold) provides some counterbalance.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $97.69 support level.